bioRxivBioinformaticsPreprint
Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator using computational approaches
Suparna BanerjeeiD, Yeshwanth MaheshiD, Dhamodharan PrabhuiD, K. SekariD, Prosenjit SeniD
- Citations
- 0
Abstract
The zymogen protease Plasminogen (Plg) and its active form plasmin (Plm) carry out important functions in the blood clot disintegration (breakdown of fibrin fibres) process. Inhibition of plasmin effectively reduces fibrinolysis to circumvent heavy bleeding. Currently, available Plm inhibitor tranexamic acid (TXA) that is used to treat severe hemorrhages is associated with an increased incidence of seizures which in turn were traced to gamma-aminobutyric acid antagonistic activity (GABAa) in addition to having multiple side effects. Fibrinolysis can be suppressed by targeting the three important protein domains: kringle-1 and serine protease domain of plasminogen and kringle-2 domain of tissue plasminogen activator. In the present study, combined approaches of structure-based virtual screening and molecular docking using Schrodinger Glide, AutoDock Vina, and ParDock/BAPPL+ were employed to identify potential hits from the ZINC database. Thereafter, the drug-likeness properties of the top three leads for each protein target were evaluated using Discovery Studio. Subsequently, a molecular dynamics simulation of 200ns for each protein-ligand complex was performed in GROMACS. The identified ligands are found to impart higher rigidity and stability to the protein-ligand complexes. Furthermore, the results were validated by performing the principal component analysis (PCA), and calculation of binding free energy using the Molecular Mechanics Poisson-Boltzmann Surface Area (MMPBSA) approach. The identified ligands occupy smaller phase space, form stable clusters and exhibit stronger non-bonded interactions. Thus, our findings can be useful for the development of promising anti-fibrinolytic agents. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/512028v2_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@b762fforg.highwire.dtl.DTLVardef@1c47591org.highwire.dtl.DTLVardef@1028dc1org.highwire.dtl.DTLVardef@a884ad_HPS_FORMAT_FIGEXP M_FIG C_FIG
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Open or closed? Exploring the conformational heterogeneity of human plasminogen across multiple resolution scales
Linda Kasiarova, Naina Verma, … Martin Marek·bioRxiv·Jul 23, 2026
- Flow alters fibrin molecular and network structure and decreases binding of fibrinolytic enzymes
Sajjad Norouzi, Ying Chou, … Sapun H. Parekh·bioRxiv·Jul 30, 2026
- A novel and potent thrombolytic fusion protein consisting of anti-insoluble fibrin antibody and mutated urokinase
S. Hanaoka, S. Saijou, Y. Matsumura·bioRxiv·Sep 6, 2020
- Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations
G. Interlandi·bioRxiv·Mar 22, 2024
- Discerning Specific Thrombolytic Activities and Blood Clot Degradomes of Diverse Snake Venoms with Untargeted Peptidomics
Cara Francesca Smith, Mamadou Aliou Baldé, … Anthony J. Saviola·Journal of Thrombosis and HaemostasisPeer-reviewed·Mar 22, 2025
- Structural control of fibrin bioactivity by mechanical deformation